The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2(+) breast cancer cells

Por Koziel, Jillian E., Herbert, Brittney-Shea
Publicado no Breast Cancer Res Treat (2015)

Medical genetics and epigenetics of telomerase

Por Koziel, Jillian E, Fox, Melanie J, Steding, Catherine E, Sprouse, Alyssa A, Herbert, Brittney-Shea
Publicado em 2011

Phenotypic plasticity in normal breast derived epithelial cells

Por Sauder, Candice AM, Koziel, Jillian E, Choi, MiRan, Fox, Melanie J, Grimes, Brenda R, Badve, Sunil, Blosser, Rachel J, Radovich, Milan, Lam, Christina C, Vaughan, Melville B, Herbert, Brittney-Shea, Clare, Susan E
Publicado em 2014